Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Primary Health Properties PLC (PHPRF)
London, GB
Primary Health Properties (PHP) holds the position of the premier investor in modern healthcare facilities throughout the UK and Ireland. Structured as a UK-based Real Estate Investment Trust (REIT), its central aim is to generate increasing shareholder returns by combining consistent earnings growth with capital appreciation. PHP accomplishes this by acquiring healthcare real estate assets that are subject to extensive lease agreements, underpinned by strong covenants primarily funded by governmental organizations. The Group's significant property collection features over 480 primary healthcare locations, including both existing and planned sites, largely consisting of general practitioner surgeries, but also encompassing premises leased to NHS entities, pharmacies, and dental practices.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +10.08% | +21.30% | -9.66% | +2.34% | +3.15% | +3.15% | -2.24% | -37.32% | -65.71% | -78.09% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth+176.1% Q4'25: +95.6% (vs Q4'23)
-
EPS growth+112.9% Q4'25: +576.1% (vs Q4'23)
-
FCF margin— Q4'25: +0.0% (vs Q4'23)
-
EBIT margin— Q4'25: +69.7% (vs Q4'23)
-
ROIC— Q4'25: +8.0% (vs Q4'23)
-
Share dilution+80.7% Q4'25: +60.0% (vs Q4'23)
-
Debt / EBITDA15.98× Q4'25: 7.01× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 1 EPS Ana. |
Dec 2027 7 Rev. Ana. 1 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 6 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
62.60M
est: 62.21M (+0.6%)
|
48.79M
est: 71.74M (-32.0%)
|
97.40M
est: 73.02M (+33.4%)
|
84.10M
est: 71.75M (+17.2%)
|
-46.50M
est: 117.95M (-139.4%)
|
139.00M
est: 129.64M (+7.2%)
|
145.60M
est: 138.15M (+5.4%)
|
154.10M
est: 141.77M (+8.7%)
|
169.80M
est: 151.56M (+12.0%)
|
93.80M
est: 156.98M (-40.2%)
|
258.96M
est: 209.98M (+23.3%)
|
334.09M
317.34M – 374.27M
+59.1% YoY
|
326.02M
307.26M – 363.78M
-2.4% YoY
|
328.33M
310.67M – 367.10M
+0.7% YoY
|
323.29M
305.91M – 361.47M
-1.5% YoY
|
328.82M
311.14M – 367.65M
+1.7% YoY
|
| EBITDA |
—
est: 29.25M (-100.0%)
|
—
est: 33.73M (-100.0%)
|
—
est: 34.33M (-100.0%)
|
—
est: 33.74M (-100.0%)
|
-90.13M
est: 55.46M (-262.5%)
|
118.00M
est: 60.95M (+93.6%)
|
126.44M
est: 64.95M (+94.7%)
|
97.63M
est: 66.66M (+46.5%)
|
—
est: 71.26M (-100.0%)
|
—
est: 72.25M (-100.0%)
|
206.97M
est: 96.64M (+114.2%)
|
153.76M
146.05M – 172.25M
+59.1% YoY
|
150.04M
141.41M – 167.42M
-2.4% YoY
|
151.11M
142.98M – 168.95M
+0.7% YoY
|
148.79M
140.79M – 166.36M
-1.5% YoY
|
151.33M
143.19M – 169.20M
+1.7% YoY
|
| EBIT |
55.46M
est: 29.02M (+91.1%)
|
59.30M
est: 33.47M (+77.2%)
|
62.60M
est: 34.07M (+83.8%)
|
66.50M
est: 33.48M (+98.6%)
|
-90.30M
est: 55.03M (-264.1%)
|
118.00M
est: 60.49M (+95.1%)
|
126.20M
est: 64.45M (+95.8%)
|
97.40M
est: 66.15M (+47.2%)
|
-900.0K
est: 70.71M (-101.3%)
|
-900.0K
est: 71.56M (-101.3%)
|
206.97M
est: 95.72M (+116.2%)
|
152.30M
144.66M – 170.61M
+59.1% YoY
|
148.62M
140.07M – 165.83M
-2.4% YoY
|
149.67M
141.62M – 167.34M
+0.7% YoY
|
147.38M
139.45M – 164.78M
-1.5% YoY
|
149.90M
141.83M – 167.60M
+1.7% YoY
|
| Net Income |
56.03M
est: 62.37M (-10.2%)
|
43.70M
est: 69.83M (-37.4%)
|
91.90M
est: 71.07M (+29.3%)
|
74.30M
est: 67.14M (+10.7%)
|
-71.30M
est: 78.24M (-191.1%)
|
112.00M
est: 77.69M (+44.2%)
|
140.10M
est: 82.50M (+69.8%)
|
56.30M
est: 86.87M (-35.2%)
|
27.30M
est: 92.08M (-70.4%)
|
41.40M
est: 166.75M (-75.2%)
|
118.98M
est: 174.79M (-31.9%)
|
177.14M
164.76M – 204.34M
+1.3% YoY
|
183.75M
170.90M – 211.95M
+3.7% YoY
|
188.96M
175.74M – 217.96M
+2.8% YoY
|
189.34M
176.10M – 218.40M
+0.2% YoY
|
192.13M
178.70M – 221.63M
+1.5% YoY
|
| SGA |
1.51M
est: 2.50M (-39.5%)
|
1.55M
est: 2.88M (-46.2%)
|
2.00M
est: 2.93M (-31.8%)
|
900.0K
est: 2.88M (-68.8%)
|
2.20M
est: 4.74M (-53.6%)
|
2.50M
est: 5.21M (-52.0%)
|
4.20M
est: 5.55M (-24.3%)
|
4.20M
est: 5.70M (-26.3%)
|
12.30M
est: 6.09M (+102.0%)
|
5.10M
est: 6.59M (-22.6%)
|
7.00M
est: 8.82M (-20.6%)
|
14.03M
13.32M – 15.71M
+59.1% YoY
|
13.69M
12.90M – 15.27M
-2.4% YoY
|
13.79M
13.04M – 15.41M
+0.7% YoY
|
13.57M
12.84M – 15.18M
-1.5% YoY
|
13.81M
13.06M – 15.44M
+1.7% YoY
|
| EPS |
0.13
est: 0.05 (+178.6%)
|
0.08
est: 0.05 (+49.3%)
|
0.15
est: 0.05 (+182.1%)
|
0.10
est: 0.05 (+99.1%)
|
-0.07
est: 0.06 (-211.5%)
|
0.09
est: 0.06 (+51.4%)
|
0.11
est: 0.06 (+78.2%)
|
0.04
est: 0.07 (-35.4%)
|
0.02
est: 0.07 (-71.0%)
|
0.03
est: 0.07 (-55.1%)
|
0.07
est: 0.07 (-8.8%)
|
0.07
0.07 – 0.08
+1.3% YoY
|
0.08
0.07 – 0.09
+3.7% YoY
|
0.08
0.07 – 0.09
+2.8% YoY
|
0.08
0.07 – 0.09
+0.2% YoY
|
0.08
0.07 – 0.09
+1.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | B | 3/5 | 5/5 | 3/5 | 3/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mark Anthony Philip Davies | Chief Executive Officer & Director | 2M | male |
| Richard Howell | Chief Financial Officer & Director | 1M | male |
| Philip Higgins | Secretary | — | male |
| Sarah Taylor | Chief People Officer | — | female |
| Steven Noble | Chief Investment Officer | — | male |
| Toby Newman | Chief Legal Officer | — | male |
| David Austin | Director of Asset, Property & Facilities Management | — | male |
| Tony Coke | Director of Development | — | male |
| David Purcell | Director of Investor Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PHPRF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
